ID: ALA4876864

Max Phase: Preclinical

Molecular Formula: C17H20Cl2N4O3

Molecular Weight: 399.28

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CC1(CCC(=O)N2CCN(c3cc(Cl)cc(Cl)c3)CC2)NC(=O)NC1=O

Standard InChI:  InChI=1S/C17H20Cl2N4O3/c1-17(15(25)20-16(26)21-17)3-2-14(24)23-6-4-22(5-7-23)13-9-11(18)8-12(19)10-13/h8-10H,2-7H2,1H3,(H2,20,21,25,26)

Standard InChI Key:  XZMNHVVTOKEKOE-UHFFFAOYSA-N

Associated Targets(Human)

ADAMTS5 711 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

ADAMTS1 32 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

ADAMTS4 425 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Matrix metalloproteinase-2 6627 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

ADAM17 3550 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 399.28Molecular Weight (Monoisotopic): 398.0912AlogP: 2.02#Rotatable Bonds: 4
Polar Surface Area: 81.75Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 8.90CX Basic pKa: 0.12CX LogP: 1.78CX LogD: 1.77
Aromatic Rings: 1Heavy Atoms: 26QED Weighted: 0.76Np Likeness Score: -1.14

References

1. Brebion F, Gosmini R, Deprez P, Varin M, Peixoto C, Alvey L, Jary H, Bienvenu N, Triballeau N, Blanque R, Cottereaux C, Christophe T, Vandervoort N, Mollat P, Touitou R, Leonard P, De Ceuninck F, Botez I, Monjardet A, van der Aar E, Amantini D..  (2021)  Discovery of GLPG1972/S201086, a Potent, Selective, and Orally Bioavailable ADAMTS-5 Inhibitor for the Treatment of Osteoarthritis.,  64  (6.0): [PMID:33719441] [10.1021/acs.jmedchem.0c02008]

Source